The TRPC6 gene helps control the flow of calcium into certain cells, especially in the kidney’s filtering units and blood vessels. This signaling helps cells sense pressure and adjust how they work. If this gene does not work properly, the kidney filter may be damaged, which can lead to protein in the urine and, in some people, a kidney condition called focal segmental glomerulosclerosis. Some variants may also influence signaling in the heart and immune system.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes hold the information needed to produce proteins, the working parts of cells. Others mainly control when certain processes take place, where they happen, and how strongly they run. As a group, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
TRPC6Gene function
What if the gene works
The TRPC6 gene helps make a cell channel that lets calcium enter cells at the right time. This supports signaling in kidney filters, blood vessels, and some immune cells.
Risk
What if the gene does not work
Variants in the TRPC6 gene are known for causing FSGS, a kidney scarring condition that can cause protein in the urine and reduced kidney function. Milder and more severe variants may lead to later or earlier symptoms.
Treatment
What does that mean for your treatment
No treatment or medicine selection approach specific to the TRPC6 gene is currently established. The TRPC6 gene is being studied as a drug target in proteinuric kidney disease, including some forms of focal segmental glomerulosclerosis, but this has not changed routine care.
Conditions associated with TRPC6
Gene function
What if the gene works
The TRPC6 gene helps cells react to everyday signals from their surroundings. It does this by making a channel in the cell membrane that lets charged particles, especially calcium, move into the cell at the right time. Knowing how the TRPC6 gene works helps explain how cells coordinate routine tasks across the body.
The TRPC6 gene makes a channel that opens in the cell membrane and allows calcium to enter. This calcium signal helps cells switch on the right actions at the right time.
Many cell surface messages can activate this channel through a small fatty signal called diacylglycerol (DAG). That gives cells a direct way to turn outside cues into internal responses.
By shaping calcium flow, the TRPC6 gene helps cells adjust movement, communication, and sometimes contraction. This supports steady function in tissues such as kidney filter cells and blood vessel muscle.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TRPC6 gene can change how this calcium channel opens, how stable it is, or whether it reaches the cell surface, which helps explain how TRPC6 gene variants affect protein function. Some changes make the channel too active, while others reduce its activity or disrupt its shape. Milder variants may cause smaller shifts in calcium flow, while more severe variants can disturb podocyte signaling more strongly and are often linked to earlier or more pronounced kidney disease.
How variants are linked to conditions
Pathogenic variants in the TRPC6 gene are best known for causing an inherited form of focal segmental glomerulosclerosis, often called FSGS. This kidney condition may show up as protein in the urine, swelling, or a gradual drop in kidney function. In families with kidney disease linked to the TRPC6 gene, finding a pathogenic variant can confirm the genetic diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the TRPC6 gene. In families with a disease-causing TRPC6 change, the gene change itself is usually the main reason risk is higher, while other influences can vary from person to person.
Inheritance of TRPC6 variants
TRPC6-related kidney disease usually follows an autosomal dominant inheritance pattern. This means a parent carrying a disease-causing variant in the TRPC6 gene can pass it to a son or daughter, and each child has a 50% chance of inheriting that variant. In families asking how TRPC6-related focal segmental glomerulosclerosis runs in families, the key point is that one changed copy of the TRPC6 gene can be enough to cause the condition.
What does my TRPC6 result mean for my family?
For TRPC6, a disease-causing result is most often linked to a dominant inherited kidney condition, so close relatives such as parents, brothers, sisters, and children may also carry the same change. That can matter even within the same family, because kidney problems may show up at different ages and can be milder or more severe from one person to another. Family members may want to discuss whether the result is relevant to them.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the TRPC6 gene, doctors use TRPC6 genetic testing on a blood or saliva sample. A lab reads the DNA code, often as part of a kidney disease panel, to check for variants linked to inherited kidney problems. Results may show a disease-causing variant, a benign variant, or an uncertain finding.
When should I consider getting a genetic test?
Genetic testing for the TRPC6 gene may be worth considering if you or close relatives have an inherited kidney condition that causes protein in the urine, reduced kidney function, or focal segmental glomerulosclerosis, a type of kidney filter scarring. It can help clarify whether the condition runs in the family.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and by the kind of variant involved. Over time, the way the body works is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may help less in another, or may cause side effects more easily, partly because the body absorbs, breaks down, or moves drugs differently. These differences are common and are one reason medication response can vary from person to person. Genetics is only one part of the picture, alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It focuses on relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the TRPC6 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so concerns about side effects, treatment changes, or new symptoms are best discussed with your doctor. TRPC6 has been studied in kidney disease research, including whether blocking its activity could help treatment in the future, but this has not become routine drug guidance.
History
The TRPC6 gene entered medical genetics through research on the broader TRP channel family in the late 1990s, when scientists were sorting out a new group of genes involved in cell signaling. In recent decades, awareness of this gene’s role has grown. A major milestone came in 2005, when variants in the TRPC6 gene were linked to inherited focal segmental glomerulosclerosis, a kidney condition that can run in families. That finding helped connect a specific gene to a form of familial kidney disease that had previously been recognized mainly by its pattern in affected relatives. From these first observations, research expanded steadily. Later studies clarified that different TRPC6 variants could be tied to different patterns of kidney involvement.